The present disclosure provides a method of biocementation comprising contacting a granular, cohesionless soil with a solution, wherein the solution comprises urea, urease, a source of calcium ions, and a source of non-urease proteins, wherein the urea, urease, source of calcium ions, and source of non-urease proteins are provided in effective amounts suitable to cause crystallization of calcium carbonate.

The present invention relates to a pharmaceutical composition for treating gout and a gout treatment kit. According to an embodiment of the present invention, a pharmaceutical composition for treating gout comprising a probe containing at least one or more peptides specifically coupled to a monosodium urate (MSU) crystals and a first enzyme which is coupled to the probe and reacts with the target MSU crystal coupled to the probe or urea of surrounding joint fluid to remove the target MSU crystal is provided.

Compositions, tools and methods for the manufacture of construction materials, masonry, solid structures and compositions to facilitate dust control are described. Compositions and methods for the manufacture of pigmented solids structures for which can be used for construction and/or decoration are also described. Manufacturing comprises fixing one or more pigments to an aggregate material such as crushed rock, stone or sand. The pigmented aggregate is incubated with urease or urease producing microorganisms, an amount of a nitrogen source such as urea, and an amount of calcium source such as calcium chloride forming calcite bridges between particles of aggregate. Using selected aggregate and pigment, the process also provides for the manufacture of simulated-stone materials such as clay or granite bricks or blocks, marble counter-tops, and more. Compositions containing microorganisms and pigment as kits that can be added to most any aggregate materials are also described.

Single domain anti-VEGFR-2 antibodies and fragments thereof and variants thereof and uses thereof, for example, for use to inhibit/decrease angiogenesis and induce tumor regression.

Single domain anti-VEGFR-2 antibodies and fragments thereof and variants thereof and uses thereof, for example, for use to inhibit/decrease angiogenesis and induce tumor regression.

A conjugate comprising an anti-VEGFR-2 antibody moiety conjugated to a urease moiety is described.

A conjugate comprising an anti-VEGFR-2 antibody moiety conjugated to a urease moiety is described.

The invention is directed to compositions, tools and methods for the manufacture of construction materials, masonry, solid structures and compositions to facilitate dust control. More particularly, the invention is directed to the manufacture of bricks, masonry and other solid structures using small amount of aggregate material that is pre-loaded with spores and/or vegetative bacterial cells.

The present invention provides methods for mineral precipitation and/or cementation of permeable or fractured non-porous materials using isolated urease.

The present invention a method for simultaneously reducing urethane and its precursors levels during Chinese liquor production process, which relates to the field of fermented food production. The present invention is carried out through inoculating Bacillus amyloliquefaciens JP21 or combines with urease into the grains for fermentation. The content of EC and urea in the fermented grains after 5-day fermentation could reduce 30.16% and 50.05% respectively, With an addition of the B. amyloliquefaciens during grains fermentation, EC and urea levels are successfully controlled, and at the same time aroma and tastes of Chinese liquor hasn't been affected.